243 related articles for article (PubMed ID: 14656660)
1. Locally delivered rhBMP-2 enhances bone ingrowth and gap healing in a canine model.
Sumner DR; Turner TM; Urban RM; Turek T; Seeherman H; Wozney JM
J Orthop Res; 2004 Jan; 22(1):58-65. PubMed ID: 14656660
[TBL] [Abstract][Full Text] [Related]
2. Locally delivered rhTGF-beta2 enhances bone ingrowth and bone regeneration at local and remote sites of skeletal injury.
Sumner DR; Turner TM; Urban RM; Leven RM; Hawkins M; Nichols EH; McPherson JM; Galante JO
J Orthop Res; 2001 Jan; 19(1):85-94. PubMed ID: 11332625
[TBL] [Abstract][Full Text] [Related]
3. Additive enhancement of implant fixation following combined treatment with rhTGF-beta2 and rhBMP-2 in a canine model.
Sumner DR; Turner TM; Urban RM; Virdi AS; Inoue N
J Bone Joint Surg Am; 2006 Apr; 88(4):806-17. PubMed ID: 16595471
[TBL] [Abstract][Full Text] [Related]
4. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations.
Wikesjö UM; Qahash M; Polimeni G; Susin C; Shanaman RH; Rohrer MD; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):1001-10. PubMed ID: 18976397
[TBL] [Abstract][Full Text] [Related]
5. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior maxilla (Type IV bone) in non-human primates.
Wikesjö UM; Huang YH; Xiropaidis AV; Sorensen RG; Rohrer MD; Prasad HS; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):992-1000. PubMed ID: 18976396
[TBL] [Abstract][Full Text] [Related]
6. Growth of new bone guided by implants in a murine calvarial model.
Freilich M; M Patel C; Wei M; Shafer D; Schleier P; Hortschansky P; Kompali R; Kuhn L
Bone; 2008 Oct; 43(4):781-8. PubMed ID: 18589010
[TBL] [Abstract][Full Text] [Related]
7. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior mandible (Type II bone) in dogs.
Wikesjö UM; Xiropaidis AV; Qahash M; Lim WH; Sorensen RG; Rohrer MD; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):985-91. PubMed ID: 18976395
[TBL] [Abstract][Full Text] [Related]
8. Depressed bone mineralization following high dose TGF-beta1 application in an orthopedic implant model.
Broderick E; Infanger S; Turner TM; Sumner DR
Calcif Tissue Int; 2005 May; 76(5):379-84. PubMed ID: 15834504
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate.
Jung RE; Weber FE; Thoma DS; Ehrbar M; Cochran DL; Hämmerle CH
Clin Oral Implants Res; 2008 Feb; 19(2):188-95. PubMed ID: 18067602
[TBL] [Abstract][Full Text] [Related]
10. [Experimental study of bone morphogenetic protein-2 in noncemented fixation of prosthesis].
Wang Y; Wang ST; Cui J; Zhou YG; Mu MW
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(4):240-3. PubMed ID: 15062046
[TBL] [Abstract][Full Text] [Related]
11. Bone formation at rhBMP-2-coated titanium implants in the rat ectopic model.
Hall J; Sorensen RG; Wozney JM; Wikesjö UM
J Clin Periodontol; 2007 May; 34(5):444-51. PubMed ID: 17448048
[TBL] [Abstract][Full Text] [Related]
12. Peri-implant reactivity and osteoinductive potential of immobilized rhBMP-2 on titanium carriers.
Chatzinikolaidou M; Lichtinger TK; Müller RT; Jennissen HP
Acta Biomater; 2010 Nov; 6(11):4405-21. PubMed ID: 20558328
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of bone formation with an in situ setting tricalcium phosphate/rhBMP-2 composite in rats.
Niedhart C; Maus U; Redmann E; Schmidt-Rohlfing B; Niethard FU; Siebert CH
J Biomed Mater Res A; 2003 Apr; 65(1):17-23. PubMed ID: 12635149
[TBL] [Abstract][Full Text] [Related]
14. Bone regeneration by recombinant human bone morphogenetic protein-2 around immediate implants: a pilot study in rats.
Matin K; Senpuku H; Hanada N; Ozawa H; Ejiri S
Int J Oral Maxillofac Implants; 2003; 18(2):211-7. PubMed ID: 12705298
[TBL] [Abstract][Full Text] [Related]
15. The effect of pretreating morselized allograft bone with rhBMP-2 and/or pamidronate on the fixation of porous Ti and HA-coated implants.
Baas J; Elmengaard B; Jensen TB; Jakobsen T; Andersen NT; Soballe K
Biomaterials; 2008 Jul; 29(19):2915-22. PubMed ID: 18407348
[TBL] [Abstract][Full Text] [Related]
16. Osteointegration of hydroxyapatite-titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep.
Sachse A; Wagner A; Keller M; Wagner O; Wetzel WD; Layher F; Venbrocks RA; Hortschansky P; Pietraszczyk M; Wiederanders B; Hempel HJ; Bossert J; Horn J; Schmuck K; Mollenhauer J
Bone; 2005 Nov; 37(5):699-710. PubMed ID: 16139577
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of BMP-2 to induce bone ingrowth in a total hip replacement model.
Bragdon CR; Doherty AM; Rubash HE; Jasty M; Li XJ; Seeherman H; Harris WH
Clin Orthop Relat Res; 2003 Dec; (417):50-61. PubMed ID: 14646702
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of recombinant human osteogenic protein-1 (rhOP-1) placed with dental implants in fresh extraction sites.
Cook SD; Salkeld SL; Rueger DC
J Oral Implantol; 1995; 21(4):281-9. PubMed ID: 8699520
[TBL] [Abstract][Full Text] [Related]
19. [Effects of bone morphogenetic protein-2 gene therapy on the bone-implant interface: an experimental study with dogs].
Yan MN; Tang TT; Zhu ZA; Zhou XS; Jia QW; Yu CF; Lou JR; Dai KR
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1521-5. PubMed ID: 16179108
[TBL] [Abstract][Full Text] [Related]
20. [Improved osseointegration of titanium implants of different surface characteristics by the use of bone morphogenetic protein (BMP-3): an animal study performed at the metaphyseal bone bed in dogs].
Hartwig CH; Esenwein SA; Pfund A; Küsswetter Dagger W; Herr G
Z Orthop Ihre Grenzgeb; 2003; 141(6):705-11. PubMed ID: 14679438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
